Cargando…

Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials

Tapinarof cream 1% (VTAMA(®); Dermavant Sciences, Inc.) is a non-steroidal, topical, aryl hydrocarbon receptor agonist approved by the US Food and Drug Administration (FDA) to treat plaque psoriasis in adults and under investigation for the treatment of psoriasis in children down to 2 years of age,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desai, Seemal R., Stein Gold, Linda, Cameron, Michael C., Golant, Alexandra, Lewitt, G. Michael, Bruno, Matthew J., Martin, George, Brown, Philip M., Rubenstein, David S., Butners, Victoria, Tallman, Anna M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539260/ https://www.ncbi.nlm.nih.gov/pubmed/37697121 http://dx.doi.org/10.1007/s13555-023-01008-9

Ejemplares similares

Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream
por: Spencer, Riley K, et al.
Publicado: (2023)

Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics
por: Jett, John E., et al.
Publicado: (2021)

Tapinarof Cream 1%: First Approval
por: Keam, Susan J.
Publicado: (2022)

Tapinarof for the treatment of psoriasis
por: Nogueira, Sofia, et al.
Publicado: (2022)

Correction: Tapinarof Cream 1%: First Approval
por: Keam, Susan J.
Publicado: (2022)

New developments in the treatment of rosacea – role of once-daily ivermectin cream
por: Cardwell, Leah A, et al.
Publicado: (2016)

Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
por: Ribero, Simone, et al.
Publicado: (2019)

Allergic Contact Dermatitis and Autoeczematization to Proctosedyl® Cream and Proctomyxin® Cream
por: Hughes, J.D. Matthew, et al.
Publicado: (2018)

First Use of Tapinarof Monotherapy for Seborrhoeic Dermatitis: A Case Report
por: ISSA, Naiem T., et al.
Publicado: (2023)

Nonulcerated Necrobiosis Lipoidica Successfully Treated with Tapinarof: A Case Report
por: Palomares, Samantha J, et al.
Publicado: (2023)

Medical Photography: Documentation, Art, and the Expression of Human Emotions
por: Aberer, Elisabeth, et al.
Publicado: (2016)

Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001)
por: Liu, Lisa, et al.
Publicado: (2023)

Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies
por: Thurston, Archie W., et al.
Publicado: (2022)

Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review
por: Torres, Tiago, et al.
Publicado: (2023)

The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
por: Rutkowski, David, et al.
Publicado: (2019)

Once-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulation
por: Shepherd, Jonisha, et al.
Publicado: (2013)

Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial
por: Stein Gold, Linda, et al.
Publicado: (2022)

Once-daily dosing of gentamicin.
por: Soper, D E
Publicado: (1998)

A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis
por: Cai, Lin, et al.
Publicado: (2020)

Safety and Efficacy of a Novel Combination Cream (GN-037) in Healthy Volunteers and Patients with Plaque Psoriasis: A Phase 1 Trial
por: Sezer, Zafer, et al.
Publicado: (2023)

Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series
por: Del Rosso, James Q., et al.
Publicado: (2022)

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups
por: Callender, Valerie D., et al.
Publicado: (2019)

Guselkumab for plaque psoriasis
Publicado: (2019)

Bimekizumab for plaque psoriasis
Publicado: (2022)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

Subject Satisfaction with Trifarotene 50 μg/g Cream in the Treatment of Facial and Truncal Acne Vulgaris: A Case Series
por: Johnson, Sandra M., et al.
Publicado: (2020)

Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp
por: García, Nuria, et al.
Publicado: (2023)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
por: Toyos, Melissa M.
Publicado: (2019)

IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis
por: Vu, Yen Hai, et al.
Publicado: (2020)

Psoriasis and staphylococcus aureus skin colonization in Moroccan patients
por: Elfatoiki, Fatima Zahra, et al.
Publicado: (2016)

Clinico-dermoscopic features of alopecia areata in patients with psoriasis
por: Tassone, Francesco, et al.
Publicado: (2018)

Use of risankizumab in two HIV-positive patients with psoriasis
por: Maliyar, Khalad, et al.
Publicado: (2023)

Benefits of once-daily therapies in the treatment of hypertension
por: Flack, John M, et al.
Publicado: (2011)

ONCE DAILY LITHIUM IN THE PROPHYLAXIS OF MOOD DISORDERS
por: Mohan, Rajesh, et al.
Publicado: (1996)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

Infliximab for the treatment of plaque psoriasis
por: Gall, Jennifer S, et al.
Publicado: (2008)

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
por: Kapitza, C, et al.
Publicado: (2013)

Méthotrexate et psoriasis: à propos de 46 cas
por: Inani, Kawtar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_spa6aoc6nlvcc80fs4o0djt3vo